Key result
VA-ECMO successfully treats a pregnant woman with acute inverted takotsubo cardiomyopathy from hemorrhagic pheochromocytoma.
Case Report (n=1)
Percutaneous va-ECMO can successfully support a pregnant patient with acute inverted takotsubo-like cardiomyopathy due to hemorrhagic pheochromocytoma.
va-ECMO may support rare pregnant cardiomyopathy cases; single report leaves open generalizability and need for validation.
We describe the first case of a pregnant woman presenting with an acute inverted takotsubo-like cardiomyopathy caused by a postpartum diagnosed hemorrhagic pheochromocytoma, successfully treated with percutaneous venoarterial extracorporeal membrane oxygenation (va-ECMO). During admission, an emergency cesarean delivery had to be performed. The fetus needed resuscitation for 5 minutes. The mother was successfully resuscitated and treated with percutaneous va-ECMO for 7 days. Despite advances in diagnostic techniques during the past decade, in many cases, pheochromocytoma in pregnancy is still missed. This results in a maternal and fetal mortality rate of up to 30% in both.
No takes yet. Share an insight, caveat, or question.
Zwet et al. (2016) conducted a case report in Acute inverted takotsubo-like cardiomyopathy from hemorrhagic pheochromocytoma in late pregnancy (n=1). Percutaneous venoarterial extracorporeal membrane oxygenation (va-ECMO) was evaluated. Percutaneous venoarterial extracorporeal membrane oxygenation (va-ECMO) successfully treated a pregnant woman with acute inverted takotsubo-like cardiomyopathy from a hemorrhagic pheochromocytoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: